Immunome Inc (IMNM) — Financial Flexibility Index
Immunome Inc (IMNM) has a Financial Flexibility Index of -1.48x as of June 2026. Free cash flow of $-59.52 Million (operating CF $-61.69 Million minus capex $2.18 Million) represents -1% of total liabilities ($40.30 Million). Check IMNM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunome Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Immunome Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Immunome Inc generate cash.
Annual Financial Flexibility Index for Immunome Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Immunome Inc. Explore Immunome Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.71x | $-181.23 Million | $-190.92 Million | $48.84 Million | ▼ -282.6% |
| 2024 | -0.97x | $-57.29 Million | $-110.79 Million | $59.08 Million | ▼ -312.5% |
| 2023 | -0.24x | $-6.74 Million | $-7.57 Million | $28.66 Million | ▲ +93.9% |
| 2022 | -3.85x | $-28.44 Million | $-28.69 Million | $7.39 Million | ▼ -106.5% |
| 2021 | -1.86x | $-18.15 Million | $-18.23 Million | $9.74 Million | ▲ +48.7% |
| 2020 | -3.63x | $-11.55 Million | $-12.13 Million | $3.18 Million | ▼ -1477.5% |
| 2019 | -0.23x | $-9.37 Million | $-9.60 Million | $40.69 Million | ▲ +4.9% |
| 2018 | -0.24x | $-7.18 Million | $-7.41 Million | $29.65 Million | — |